Use of Aspirin in normalization of recombinant human erythropoietin-mediated hyper-reactivity of platelets in rats

OBJECTIVES: The cytokine erythropoietin is the primary stimulator of erythropoiesis and recombinant human erythropoietin (rHuEPO), which is widely used in the treatment of anemia associated with advanced chronic kidney disease (CKD). Adverse cardiovascular outcomes have been observed during clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Soni, Hitesh M., Vekaria, Amit M., Rath, Akshyaya C., Belemkar, Sateesh, Jain, Mukul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071712/
https://www.ncbi.nlm.nih.gov/pubmed/24987182
http://dx.doi.org/10.4103/0253-7613.132187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071712/
https://www.ncbi.nlm.nih.gov/pubmed/24987182
http://dx.doi.org/10.4103/0253-7613.132187

Ejemplares similares